Opinion|Videos|March 11, 2025
Quality of Life and Patient Outcomes in mCRC Treatment
Experts discuss practical strategies used by their institutions to manage treatment-related toxicities with third-line therapies for metastatic colorectal cancer (mCRC) and share their experiences on how third-line therapy options have impacted patients’ quality of life.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What practical strategies does your institution use to manage treatment-related toxicities with third-line therapies for mCRC?
- In your experience, how have the third-line therapy options impacted your patients’ quality of life?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
US Employer Health Care Costs Projected to Rise 9.5% in 2027
3
Student Mental Health, Success Tied to Future Health and Affordability
4
FDA Approves First Orexin Agonist for Narcolepsy Type 1
5